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ABSTRACT 
In situ preparation of hydroxyapatite
carried out by the wet chemical precipitation method using water, ethanol, ethyl acetate 
and acetone as the dissolution medium. Drug loading was carried out at neutral pH, while 
in vitro drug release study was carried out in synthetic body fluid (SBF) at pH 7.4 and 37 
oC.  The FTIR results show similar functional groups for precursors and synthesized 
nanocomposites. The nanocomposite prepared in water medium has the highest drug 
encapsulation efficiency of 83.67 %. Doxorubicin release profile comparison using 
difference factor (f1), showed that there is no significant difference between release 
profile of doxorubicin from nanocomposite synthesized in acetone and ethyl acetate ((f
3.92), while other release profiles differed significantly. All the formulations follow first 
order release rate, while the n exponent in the Korsmeyer
the release mechanism is dominated by Fickian diffusion. The release prof
indicate that nanocomposites synthesized from water medium is a better delivering 
agent for doxorubicin than the nanocomposites from the others solvents.
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INTRODUCTION 
Drug delivery system refers to the technology 
used to present the drug to the desired body 
site for release and absorption (Shargel 
2012). Because of their ability to overcome 
drawbacks of conventional dosage forms, these 
modified-release forms are increasingly replacing 
the conventional dosage forms (Dixit 
2013). Some categories of modified release 
delivery system are: sustained-release, delayed
release, and targeted-release drug delivery 
systems. 
Targeted release drug delivery system 
system that selectively delivers drugs only to the 
required physiological sites, organs or cells, 
while reducing/avoiding delivery to the 
unwanted sites. Targeted delivery systems lead 
to improved therapeutic index and reduced side 
effects (Masayuk, 2005). Delayed release drug 
delivery system is a drug carrier that releases 
the drug at a time other than immediately after 
administration (Shargel et al., 2012); while 
sustained release drug delivery system is a 
delivery system designed to achieve prolong
therapeutic effect by continuously releasing the 
therapeutic agent over an extended period of 
time after administration of single dose (
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-sodium alginate nanocomposite (HASA) was 








et al, 2013). Sustained release drug delivery 
systems alter the pharmacodynamics and 
pharmacokinetics of the drug by modifying the 
rate at which the drug is being released into the 
system (Dixit et al, 2013). This leads to several 
advantages over conventional dosage for
which include, improved patient compliance as a 
result of less frequent drug administration
reduction in fluctuation of plasma drug levels, 
maximal utilization of the drug, reduction in 
health care costs, and reduction in dose
dependent toxicity (Patnaik et al, 2013).
The aim of an ideal cancer chemotherapy is to 
deliver the correct amount of drug at controlled 
rate for sufficiently long time (sustained release) 
to the site of action (tumour cells) while 
minimizing contact with normal cells (targeted 
release). Conventional dosage forms result in 
fluctuation of drug concentration giving rise to 
peak and valley patterns. This leads to drug 
concentrations sharply rising above toxic level 
(maximum tolerated dose (MTD) or minimum 
toxic concentration (MTC) and within a short 
time falling below the minimum effective
concentration (MEC). Figure 1 
comparison between the sustained drug release 
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Figure 1: Schematic representation of conventional drug release profile and controlled release profile  
 
It has been shown that the drug loading 
efficiency and controlled release behaviour can 
be enhanced because of the synergistic effect 
between biopolymer and inorganic materials 
(Devanand et al., 2011) Hydroxyapatite/polymer 
composites have attracted much attention since 
such composite lead to improved properties 
(Khaled et al., 2014) as a result of improvement 
in the surface functionality of the apatite 
(Venkatesan et al., 2011). Such improvement 
has led to wide applications of hydroxyapatite 
polymer composite in many areas such as in 
drug delivery system (Andronescu et al., 2010; 
Venkatesan et al., 2011; Sivakumar, and Raj et 
al., 2013). Incorporation of hydroxyapatite into 
polymer structure has resulted in less burst 
release and more sustained release of the 
encapsulated drug (Devanand et al., 2011; 
Krisanapiboon et al., 2006; Cypes et al., 2003; 
Yao et al., 2010). Conditions used in the 
synthesis of drug carrier is an important factor in 
burst release. 
Release of drug is governed by several factors 
such as nature and molecular weight of the 
drug, degree of cross linking, density, pore size 
of the matrix, solvent type etc. (Narayana et al. 
2011). Solvent plays an important role in a given 
chemical reaction. Solubility, equilibrium position 
and reaction rate are all affected by solvent. 
Solvent has direct effect on the particle size, 
surface morphology, drug encapsulation 
efficiency and release behaviour (Narayana et 
al., 2011). Solvent system affected morphology 
and diameter of fibers, which directly affected 
oflaxacin loading and microbiological activity of 
the fiber (Karatas et al. 2016). Morphology of 
coreshell nanoparticle depends on the nature of 
solvent chosen. (Joshi et al. 2017). While 
solvents influenced morphological homogeneity 
and surface area of hollow nickel-silica 
composite (Umegaki et al. 2014). Study by Mai 
et al. (2017), also showed that solvent has 
significant impact on the morphology of 
microcapsules. 
Solvents affect morphology due to different 
ways solvents interact with the precursors 
(Khoza et al. 2012). It is well known that the 
shape and size of the material strongly affect the 
properties and the applications of the material 
(Moloto et al. 2009; Jun et al. 2006; Tang et al. 
2000; Yang et al. 2000). Klose et al. (2006) 
reported how porosity and size of the particles 
affect the drug release mechanisms from PLGA-
based microparticles. 
The presence of pores does not only increase 
the mobility of the drug molecules, but 
fundamentally alters the underlying drug release 
mechanisms. Generally, the release of 
encapsulated particles during the degradation 
process will be faster in the case of porous 
particles.  Morphology influence the 
biodegradation kinetics of polymers which can 
dictate the release rate of the encapsulated drug 
(Badri et al., 2014).  
Solvent selection continues to be one of the 
most challenging issues for current synthetic 
chemistry since most of chemical or biochemical 
reactions on the earth occur in wet environment 
(Jiang et al. 2014). The aim of this research is to 
evaluate the effect of using different solvents in 
the preparation of hydroxyapatite sodium 
alginate composite (HASA) on doxorubicin 
loading and release profiles. Based on toxicity 
profiles, water, ethanol, ethyl acetate and 
acetone were selected for this study.  
 
MATERIALS AND METHODS 
Preparation of HASA Nanocomposite in 
Different Solvents 
Calcium nitrate tetrahydrate solutions (0.10M) 
(400 cm3) prepared in different solvents (water, 
ethanol, ethylacetate, and acetone) were 
separately added in drop-wise manner to 
different SA aqueous solutions (100 cm3) 
(50%wt) while stirring vigorously. The 
temperature of the one prepared in acetone 
solution was raised to above 37oC. 
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This mixture was set on a magnetic stirrer, and 
50 cm3 of 0.06 M diammonium hydrogen 
phosphate aqueous solution ((NH4)2HPO4) was 
added to it dropwise with continuous stirring. 
The stirring was continued for 24 h. The pH was 
maintained at approximately 10.5 throughout 
the experiment using 1 M sodium hydroxide. 
The suspension was then stored for 24 h at 
room temperature for aging, after which the 
precipitate was separated by centrifugation, and 
subsequently washed with distilled water three 
times. The resulting gel-like paste was dried at 
60oC for 24 h and then ground using agate 
mortar to obtain fine powders. The 
nanocomposites were then used for drug loading 
and release study as previously reported 
(Onoyima et al. 2017).  
Drug Release Kinetics and Mechanistic 
Study 
In order to elucidate the release kinetics and the 
mechanism of drug release, the data was fitted 
into zero order model, first order model, Higuchi 
model, Korsmeyer-Peppas model, Hixon-Crowel 
model, and Hopfenberg model. This was done 
using a combination of DDSolver software and 
excel sheet. 
Comparison of Drug Release Profiles 
A release profile is a measurement of in vitro 
drug release from a preparation in receptacle 
media over a period of time. Similarities 
between the different release profiles were 
investigated using model-independent approach. 
Pairwise procedures were followed, while 
similarity factor (f2) and the difference factor (f1) 
were chosen for comparison (Zhang et al., 2010) 
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Where, n is the number of time points and Rt 
and Tt are the average percentage of drugs 
released in reference and test products 
respectively at time t. The value of f2 falls 
between 0 and 100, and two profiles are 
considered to be similar when f2 ranges between 
50 and 100 (Zuo et al., 2014). f1 is zero when 
the test and reference profiles are identical and 
increases proportionally with the dissimilarity 
between the two profiles. f1 values above 15 are 
considered dissimilar (Moore and Flanner, 1996). 
In order to reduce calculation time and eliminate 
calculation errors, DDSolver program (excel 
plug-in program) was used for the calculations. 
 
RESULTS AND DISCUSSION 
Fourier-Transform Infrared Analyses of 
Precursors and the Synthesized 
Nanocomposites    
Spectrum of SA (Figure 2) exhibited peaks which 
are in agreement with those reported in 
literature. The HA peak values (Figure 3) are 
similar to those reported for HA by Roul et al. 
(2013); Rajkumar et al. (2010); Nabipour et al. 
(2016). The formation of the nanocomposite 
was confirmed by the spectrum of HASA in 
Figure 4. It was observed that the peak at 
3236.3 cm-1 in alginate shifted to 3220.4 cm3, 
while the peaks at 1595.3 cm-1 and 1405.2 cm-1 
shifted to 1599.0 cm-1 and 1408.9 cm-1 
respectively. As divalent metal ions replace 
sodium ions in the SA, the charge density, the 
radius and atomic weight of the cation are 
different, creating a new environment around 
the carbonyl group, hence the observed peak 
shift (Azami et al., 2010). This also leads to the 
formation of new peak at 1341.8 cm-1. It has 
been documented that formation of chemical 
bond between carbonyl group and divalent 
metal leads to a new peak around 1340 cm-1 
(Kikuchi et al., 2004; Itoh et al., 2005; Azami et 
al., 2010;).  
 
 
Figure 2: FTIR spectra of hydroxyapatite (HA) and sodium alginate (SA) 
The FTIR study (Figure 3) indicated that replacement of water with organic solvent did not introduce 
additional functional group to the material as they had similar absorption peaks. That is to say that 
the differences in loading and release profiles was not due to presence/absence of chemical 
interaction but probably due to physical difference in microstructure of the nanocomposites. 
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Figure 3: FTIR spectra of HASA synthesized under water, Ethanol, Acetone, and   Ethyl acetate 
media 
 
Effect of Medium of Synthesis on Drug 
Loading and Release 
Nanocomposites prepared in different solvents 
were loaded with DOX to investigate the effect 
of these solvents on the loading and release of 
DOX. The result of the drug loading (Figure 4) 
showed that nanocomposites prepared using 
distilled water had highest DOX loading 
efficiency of 83.67%. This was followed by 
nanocomposites prepared in ethanol medium 
with loading efficiency of 52.46%, while 
nanocomposites prepared in acetone medium 
and ethyl acetate medium had approximately 




Figure 4: DOX encapsulation efficiency from nanocomposites prepared in different Solvents 
 
From the drug release profile (Figure 5), it is 
interesting to note that nanocomposite prepared 
in aqueous medium which exhibited highest 
loading efficiency had slower release rate, hence 
more sustained release than other formulations. 
The release half time (t50) (time required for 
releasing 50% of the loaded drug) for water 
formulation, ethanol formulation, acetone 
formulation and ethyl acetate formulation were 
16 hours, 8 hours, 4 hours and 4 hours 
respectively (Figure 4). Jalil, and Nixon (1990) 
has reported that increase in removal rate of 
organic solvents causes increase in porosity of 
the matrices, and consequently higher release 
rate.
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Hence, the higher release rate of the organic 
solvents formulations observed in this study may 
be attributed to higher porosity of the 
composites caused by higher removal rate of the 
organic solvents relative to water. 
 Profile comparison showed that water 
formulation and other organic solvent 
formulations are significantly different. The 
difference factor (f1) for water versus ethanol, 
water versus acetone, and water versus ethyl 
acetate are 23.96, 47.10, and 51.26 
respectively. Among all the release profiles, only 
the profiles of acetone formulation and ethyl 
acetate formulation did not show significant 
difference (f1 = 3.92) (Table 1) 
 
 
Figure 5: DOX release profiles from nanocomposites prepared in different media    
                (solvents) 
 
Table 1: Comparison of DOX release profiles from nanocomposites synthesised in  
               different media (solvents) using difference factors (f1) 
Water Ethanol Acetone Ethylacetate 
Water   0 
Ethanol 23.96    0 
Acetone 47.1 18.67    0 
Ethyl acetate 51.26 22.02 3.92     0 
 
All the formulations followed first order release 
rate, while the n exponent in the Korsmeyer-
Peppas equation indicates that the release 
mechanism was dominated by Fickian diffusion. 
In addition, the formulations with organic 
solvents showed good fit with Higuchi model, 
Hixon-Crowel model, and Hopfenberg model, 
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Table 2: Kinetic and mechanistic models of DOX release from HASA synthesized in different solvents 
MODEL 
 
PARAMETER WATER ACETONE  ETHANOL ETHYLACETATE 
Zero Order 
 
R2 0.7837   0.8244  0.8479  
 
0.7729  
R2-adj 0.7405  0.7892  0.8175  0.7275  
MSC 0.9597 1.168 1.312 0.911 
K0 (mol.L
-1s-1) 1.021 1.421 1.233 1.33 
First Order 
 
R2 0.9297  0.9749  0.9501  0.9600  
R2-adj 0.9157  0.9698  0.9401  0.9520  
MSC 2.083  3.112  2.426  2.646  
K1 (s-1) 0.224  0.0670  0.0370  0.0710  
Korsmeyer-Peppas  R2 0.9722  0.9916  0.9977  0.9864  
R2-adj 0.9629  0.9888  0.9969  0.9818  
MSC 2.782  3.979  5.277  3.494  
N 0.4410  0.372  0.345 0.349 
Higuchi R2 0.9222  0.9503  0.9638  0.9192  
R2-adj 0.9066  0.9403  0.9566  0.9030  
MSC 1.982  2.428  2.748  1.944  
KH  8.377 11.53  9.937  10.99 
Hixon-Crowel 
 
R2 0.8314  0.9488  0.9196  0.9286  
R2-adj 0.7977  0.9385  0.9036  0.9143  
MSC 1.208  2.399  1.949  2.067  
KHC 0.006 0.0160  0.0090  0.0180  
Hopfenberg R2 0.8560  0.9747  0.9500  0.9599  
R2-adj 0.7841  0.9621  0.9250  0.9398  
 
 MSC  1.081  2.820  2.138  2.359  
N  648.9 399.4 928.2 1029 
 
CONCLUSION 
Based on the toxicity profiles of the solvents 
used and the loading and release study, it can 
be concluded that it is not necessary to use 
these organic solvents for the synthesis of the 
nanocomposites. Nanocomposite prepared in 
aqueous medium had better loading and release 
profile, and water is non-toxic to the body 
system as compared to organic solvents.
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